Karuna Therapeutics Inc.

NASDAQ: KRTX · Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 8:00 PM

Karuna Therapeutics Statistics

Share Statistics

Karuna Therapeutics has 38.2M shares outstanding. The number of shares has increased by 0% in one year.

38.2M
0%
0%
n/a
n/a
3
n/a

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is -26.97 and the forward PE ratio is null. Karuna Therapeutics's PEG ratio is -0.79.

-26.97
n/a
17886.71
n/a
9.33
-30.09
-0.79
Financial Ratio History

Enterprise Valuation

Karuna Therapeutics has an Enterprise Value (EV) of 11.53B.

17628.09
-23.38
-29.88
-29.66

Financial Position

The company has a current ratio of 19.31, with a Debt / Equity ratio of 0.01.

19.31
18.82
0.01
-0.03
-0.04
0

Financial Efficiency

Return on Equity is -34.58% and Return on Invested Capital is -38.99%.

-34.58%
-32.46%
-38.99%
$1,929.2
$-1,279,292.04
339
0
0.05

Taxes

670K
-0.15%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.15, so Karuna Therapeutics's price volatility has been higher than the market average.

1.15
n/a
317.67
228.83
75.4
971,825

Income Statement

In the last 12 months, Karuna Therapeutics had revenue of 654K and earned -433.68M in profits. Earnings per share was -11.73.

654K
-1.05M
-494.78M
-433.68M
-493.08M
n/a
-11.73
Full Income Statement

Balance Sheet

The company has 185.82M in cash and 16.69M in debt, giving a net cash position of 169.13M.

185.82M
16.69M
169.13M
-997.89M
1.34B
1.25B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -385.82M and capital expenditures -2.92M, giving a free cash flow of -388.74M.

-385.82M
-2.92M
-388.74M
-10.52
Full Cash Flow Statement

Margins

Gross margin is -160.09%, with operating and profit margins of -75653.98% and -66311.93%.

-160.09%
-75653.98%
-66209.48%
-66311.93%
-75393.88%
-75653.98%
-59439.76%

Dividends & Yields

KRTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-3.71%
-3.32%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for KRTX.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

91.07
1